Liu B, Granville DJ, Golledge J, et al., 2020, Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm. Am J Physiol Heart Circ Physiol, 318: H652– H670. https://doi.org/10.1152/ajpheart.00621.2019

Shen YH, LeMaire SA, Webb NR, et al., 2020, Aortic aneurysms and dissections series. Arterioscler Thromb Vasc Biol, 40: e37–e46. https://doi.org/10.1161/atvbaha.120.313991

Zhang L, Bhaloo SI, Chen T, et al., 2018, Role of resident stem cells in vessel formation and arteriosclerosis. Circ Res, 122: 1608–1624. https://doi.org/10.1161/circresaha.118.313058 

Petsophonsakul P, Furmanik M, Forsythe R, et al., 2019, Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation. Arterioscler Thromb Vasc Biol, 39: 1351–1368. https://doi.org/10.1161/atvbaha.119.312787 

Clancy K, Wong J, Spicher A, 2019, Abdominal aortic aneurysm: A case report and literature review. Perm J, 23: 18.218. https://doi.org/10.7812/tpp/18.218

Quintana RA, Taylor WR, 2019, Introduction to the compendium on aortic aneurysms. Circ Res, 124: 470–471. https://doi.org/10.1161/circresaha.119.314765

Quintana RA, Taylor WR, 2019, Cellular mechanisms of aortic aneurysm formation. Circ Res, 124: 607–618. https://doi.org/10.1161/circresaha.118.313187

Hellawell HN, Mostafa AM, Kyriacou H, et al., 2021, Abdominal aortic aneurysms part one: Epidemiology, presentation and preoperative considerations. J Perioper Pract, 31: 274–280. https://doi.org/10.1177/1750458920954014

Boczar KE, Cheung K, Boodhwani M, et al., 2019, Sex differences in thoracic aortic aneurysm growth. Hypertension, 73: 190–196. https://doi.org/10.1161/hypertensionaha.118.11851

Wesche J, 2009, Epidemiology, investigation and treatment indication in aortic aneurysm. Tidsskr Nor Laegeforen, 129: 2124–2126. https://doi.org/10.4045/tidsskr.09.0160

Zhou Z, Cecchi AC, Prakash SK, et al., 2022, Risk factors for thoracic aortic dissection. Genes (Basel), 13: 1814. https://doi.org/10.3390/genes13101814 

Sayed A, Munir M, Bahbah EI, 2021, Aortic dissection: A review of the pathophysiology, management and prospective advances. Curr Cardiol Rev, 17: e230421186875. https://doi.org/10.2174/1573403x16666201014142930 

Gurung R, Choong AM, Woo CC, et al., 2020, Genetic and epigenetic mechanisms underlying vascular smooth muscle cell phenotypic modulation in abdominal aortic aneurysm. Int J Mol Sci, 21: 6334. https://doi.org/10.3390/ijms21176334 

Chakraborty R, Saddouk FZ, Carrao AC, et al., 2019, Promoters to study vascular smooth muscle. Arterioscler Thromb Vasc Biol, 39: 603–612. https://doi.org/10.1161/atvbaha.119.312449

Ferruzzi J, Murtada SI, Li G, et al., 2016, Pharmacologically improved contractility protects against aortic dissection in mice with disrupted transforming growth factor-β signaling despite compromised extracellular matrix properties. Arterioscler Thromb Vasc Biol, 36: 919–927. https://doi.org/10.1161/atvbaha.116.307436

Clément M, Chappell J, Raffort J, et al., 2019, Vascular smooth muscle cell plasticity and autophagy in dissecting aortic aneurysms. Arterioscler Thromb Vasc Biol, 39: 1149– 1159. https://doi.org/10.1161/atvbaha.118.311727 

Furmaniak-Kazmierczak E, Crawley SW, Carter RL, et al., 2007, Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells. Circ Res, 100: 1328–1336. https://doi.org/10.1161/circresaha.106.147744 

Duca L, Blaise S, Romier B, et al., 2016, Matrix ageing and vascular impacts: Focus on elastin fragmentation. Cardiovasc Res, 110: 298–308. https://doi.org/10.1093/cvr/cvw061 

Halushka MK, Angelini A, Bartoloni G, et al., 2016, Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European cardiovascular pathology: II. Noninflammatory degenerative diseases-nomenclature and diagnostic criteria. Cardiovasc Pathol, 25: 247–257. https://doi.org/10.1016/j.carpath.2016.03.002

Qin Y, Cao X, Guo J, et al., 2012, Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Cardiovasc Res, 96: 401–410. https://doi.org/10.1093/cvr/cvs263

Jana S, Hu M, Shen M, et al., 2019, Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm. Exp Mol Med, 51: 1–15. https://doi.org/10.1038/s12276-019-0286-3 

Sun J, Sukhova GK, Zhang J, et al., 2012, Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol, 32: 15–23. https://doi.org/10.1161/atvbaha.111.235002 

Sun J, Sukhova GK, Zhang J, et al., 2011, Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol, 31: 2500-2508. https://doi.org/10.1161/atvbaha.111.230201

Infantes D, Nus M, Navas-Madroñal M, et al., 2021, Oxidative stress and inflammatory markers in abdominal aortic aneurysm. Antioxidants (Basel), 10: 602. https://doi.org/10.3390/antiox10040602

Emeto TI, Moxon JV, Au M, et al., 2016, Oxidative stress and abdominal aortic aneurysm: Potential treatment targets. Clin Sci (Lond), 130: 301–315. https://doi.org/10.1042/cs20150547

Li Z, Kong W, 2020, Cellular signaling in abdominal aortic aneurysm. Cell Signal, 70: 109575. https://doi.org/10.1016/j.cellsig.2020.109575

Wiernicki I, Parafiniuk M, Kolasa-Wołosiuk A, et al., 2019, Relationship between aortic wall oxidative stress/proteolytic enzyme expression and intraluminal thrombus thickness indicates a novel pathomechanism in the progression of human abdominal aortic aneurysm. FASEB J, 33: 885–895. https://doi.org/10.1096/fj.201800633R 

Lu H, Daugherty A, 2017, Aortic aneurysms. Arterioscler Thromb Vasc Biol, 37: e59–e65. https://doi.org/10.1161/atvbaha.117.309578

Davis FM, Daugherty A, Lu HS, 2019, Updates of recent aortic aneurysm research. Arterioscler Thromb Vasc Biol, 39: e83–e90. https://doi.org/10.1161/atvbaha.119.312000

Dale MA, Ruhlman MK, Baxter BT, 2015, Inflammatory cell phenotypes in AAAs: Their role and potential as targets for therapy. Arterioscler Thromb Vasc Biol, 35: 1746–1755. https://doi.org/10.1161/atvbaha.115.305269

Meher AK, Spinosa M, Davis JP, et al., 2018, Novel role of IL (Interleukin)-1/10. neutrophil extracellular trap formation and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 38: 843–853. https://doi.org/10.1161/atvbaha.117.309897

Pedroza AJ, Tashima Y, Shad R, et al., 2020, Single-cell transcriptomic profiling of vascular smooth muscle cell phenotype modulation in Marfan syndrome aortic aneurysm. Arterioscler Thromb Vasc Biol, 40: 2195–2211. https://doi.org/10.1161/atvbaha.120.314670 

Wu D, Ren P, Zheng Y, et al., 2017, NLRP3 (Nucleotide oligomerization domain-like receptor family, Pyrin domain containing 3)-caspase-1 inflammasome degrades contractile proteins: Implications for aortic biomechanical dysfunction and aneurysm and dissection formation. Arterioscler Thromb Vasc Biol, 37: 694–706. https://doi.org/10.1161/atvbaha.116.307648

Portelli SS, Hambly BD, Jeremy RW, et al., 2021, Oxidative stress in genetically triggered thoracic aortic aneurysm: Role in pathogenesis and therapeutic opportunities. Redox Rep, 26: 45–52. https://doi.org/10.1080/13510002.2021.1899473

Irace FG, Cammisotto V, Valenti V, et al., 2021, Role of oxidative stress and autophagy in thoracic aortic aneurysms. JACC Basic Transl Sci, 6: 719–730. https://doi.org/10.1016/j.jacbts.2021.08.002

Isselbacher EM, Lino Cardenas CL, Lindsay ME, 2016, Hereditary influence in thoracic aortic aneurysm and dissection. Circulation, 133: 2516–2528. https://doi.org/10.1161/circulationaha.116.009762

Milewicz DM, Trybus KM, Guo DC, et al., 2017, Hereditary influence in thoracic aortic aneurysm and dissection. Circulation, 133: 2516–2528. https://doi.org/10.1161/circulationaha.116.009762 

Yang H, Zhou T, Stranz A, et al., 2021, Single-Cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm-brief report. Arterioscler Thromb Vasc Biol, 41: 1158–1166. https://doi.org/10.1161/atvbaha.120.315607

Zhao G, Lu H, Chang Z, et al., 2021, Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta. Cardiovasc Res, 117: 1402–1416. https://doi.org/10.1093/cvr/cvaa214

Qian W, Hadi T, Silvestro M, et al., 2022, Microskeletal stiffness promotes aortic aneurysm by sustaining pathological vascular smooth muscle cell mechanosensation via Piezo1. Nat Commun, 13: 512. https://doi.org/10.1038/s41467-021-27874-5

Hadi T, Boytard L, Silvestro M, et al., 2018, Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells. Nat Commun, 9: 5022. https://doi.org/10.1038/s41467-018-07495-1

Li B, Song X, Guo W, et al., 2021, Single-cell transcriptome profiles reveal fibrocytes as potential targets of cell therapies for abdominal aortic aneurysm. Front Cardiovasc Med, 8: 753711. https://doi.org/10.3389/fcvm.2021.753711

Weng Y, Lou J, Bao Y, et al., 2022, Single-cell RNA sequencing technology revealed the pivotal role of fibroblast heterogeneity in angiotensin ii-induced abdominal aortic aneurysms. DNA Cell Biol, 41: 498–520. https://doi.org/10.1089/dna.2021.0923 

Liu X, Chen W, Zhu G, et al., 2022, Single-cell RNA sequencing identifies an Il1rn(+)/Trem1(+) macrophage subpopulation as a cellular target for mitigating the progression of thoracic aortic aneurysm and dissection. Cell Discov, 8: 11. https://doi.org/10.1038/s41421-021-00362-2

Luo W, Wang Y, Zhang L, et al., 2020, Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture. Circulation, 141: 42–66. https://doi.org/10.1161/circulationaha.119.041460

Li Y, Ren P, Dawson A, et al., 2020, Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue. Circulation, 142: 1374–1388. https://doi.org/10.1161/circulationaha.120.046528

Davis FM, Tsoi LC, Melvin WJ, et al., 2021, Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms. J Exp Med, 218: e20201839. https://doi.org/10.1084/jem.20201839

Dawson A, Li Y, Li Y, et al., 2021, Single-cell analysis of aneurysmal aortic tissue in patients with Marfan syndrome reveals dysfunctional TGF-rosignaling. Genes (Basel), 13: 95. https://doi.org/10.3390/genes13010095 

Yu B, Chen Q, Le Bras A, et al., 2018, Vascular stem/ progenitor cell migration and differentiation in atherosclerosis. Antioxid Redox Signal, 29: 219–235. https://doi.org/10.1089/ars.2017.7171 

Skurikhin EG, Krupin VA, Pershina OV, et al., 2018, Endothelial progenitor cells and notch-1 signaling as markers of alveolar endothelium regeneration in pulmonary emphysema. Bull Exp Biol Med, 166: 201–206. https://doi.org/10.1007/s10517-018-4314-4

Chambers SE, Pathak V, Pedrini E, et al., 2021, Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl Med, 10 Suppl 2(Suppl 2): S54– S61. https://doi.org/10.1002/sctm.21-0022

Sung SH, Wu TC, Chen JS, et al., 2013, Reduced number and impaired function of circulating endothelial progenitor cells in patients with abdominal aortic aneurysm. Int J Cardiol, 168: 1070–1077. https://doi.org/10.1016/j.ijcard.2012.11.002

Bingol B, Elcik D, Kutuk S, et al., 2022, Endothelial progenitor cells and NADPH oxidase enzyme activity in the development of an aortic aneurysm. Braz J Cardiovasc Surg, 37: 501–510. https://doi.org/10.21470/1678-9741-2020-0458

Eizawa T, Ikeda U, Murakami Y, et al., 2004, Increase in circulating endothelial progenitor cells after aortic aneurysm repair. Heart Vessels, 19: 107–110. https://doi.org/10.1007/s00380-003-0751-7

Wu W, Zhang J, Shao L, et al., 2022, Evaluation of circulating endothelial progenitor cells in abdominal aortic aneurysms after endovascular aneurysm repair. Int J Stem Cells, 15: 136–143. https://doi.org/10.15283/ijsc21027

Shi C, Shen C, Liu G, et al., 2021, NEAT1 promotes the repair of abdominal aortic aneurysms of endothelial progenitor cells via regulating miR-204-5p/Ang-1. Am J Transl Res, 13: 2111–2126. 

Li X, Wei Z, Chen Y, 2022, CXCL12 regulates bone marrow-derived endothelial progenitor cells to promote aortic aneurysm recovery. Tissue Cell, 77: 101810. https://doi.org/10.1016/j.tice.2022.101810

Kavyasudha C, Joseph JP, Jayaraj R, et al., 2021, Conventional and emerging markers in stem cell isolation and characterization. Adv Exp Med Biol, 1341: 1–14. https://doi.org/10.1007/5584_2019_475

Aggarwal S, Pittenger MF, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105: 1815–1822. https://doi.org/10.1182/blood-2004-04-1559

Zhou YZ, Cheng Z, Wu Y, et al., 2019, Mesenchymal stem cell-derived conditioned medium attenuate angiotensin II-induced aortic aneurysm growth by modulating macrophage polarization. J Cell Mol Med, 23: 8233–8245. https://doi.org/10.1111/jcmm.14694

Sharma AK, Lu G, Jester A, et al., 2012, Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation, 126(11 Suppl 1): S38–S45.https://doi.org/10.1161/circulationaha.111.083451

Hawkins RB, Salmon M, Su G, et al., 2021, Mesenchymal stem cells alter microRNA expression and attenuate thoracic aortic aneurysm formation. J Surg Res, 268: 221–231. https://doi.org/10.1016/j.jss.2021.06.057

Zhang H, Wang Y, Bian X, et al., 2021, MicroRNA-194 acts as a suppressor during abdominal aortic aneurysm via inhibition of KDM3A-mediated BNIP3. Life Sci, 277: 119309. https://doi.org/10.1016/j.lfs.2021.119309

Spinosa M, Lu G, Su G, et al., 2018, Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147. FASEB J, 32: fj201701138RR. https://doi.org/10.1096/fj.201701138RR

Swaminathan G, Stoilov I, Broekelmann T, et al., 2018, Phenotype-based selection of bone marrow mesenchymal stem cell-derived smooth muscle cells for elastic matrix regenerative repair in abdominal aortic aneurysms. J Tissue Eng Regen Med, 12: e60–e70. https://doi.org/10.1002/term.2349

Mildmay-White A, Khan W, 2017, Cell surface markers on adipose-derived stem cells: A systematic review. Curr Stem Cell Res Ther, 12: 484–492. https://doi.org/10.2174/1574888x11666160429122133

Xie J, Jones TJ, Feng D, et al., 2017, Human adipose-derived stem cells suppress elastase-induced murine abdominal aortic inflammation and aneurysm expansion through paracrine factors. Cell Transplant, 26: 173–189. https://doi.org/10.3727/096368916x692212

Hu J, Jiang Y, Wu X, et al., 2022, Exosomal miR-17-5p from adipose-derived mesenchymal stem cells inhibits abdominal aortic aneurysm by suppressing TXNIP-NLRP3 inflammasome. Stem Cell Res Ther, 13: 349. https://doi.org/10.1186/s13287-022-03037-1

Huang X, Zhang H, Liang X, et al., 2019, Adipose-derived mesenchymal stem cells isolated from patients with abdominal aortic aneurysm exhibit senescence phenomena. Oxid Med Cell Longev, 2019: 1305049. https://doi.org/10.1155/2019/1305049

Zou S, Ren P, Zhang L, et al., 2020, Activation of bone marrow-derived cells and resident aortic cells during aortic injury. J Surg Res, 245: 1–12. https://doi.org/10.1016/j.jss.2019.07.013

Sho E, Sho M, Nanjo H, et al., 2004, Hemodynamic regulation of CD34+ cell localization and differentiation in experimental aneurysms. Arterioscler Thromb Vasc Biol, 24: 1916–1921. https://doi.org/10.1161/01.Atv.0000142805.20398.74

Gong J, Zhou D, Jiang L, et al., 2020, In vitro lineage-specific differentiation of vascular smooth muscle cells in response to SMAD3 deficiency: Implications for SMAD3-related thoracic aortic aneurysm. Arterioscler Thromb Vasc Biol, 40: 1651–1663. https://doi.org/10.1161/atvbaha.120.313033

Wang G, Jacquet L, Karamariti E, et al., 2015, Origin and differentiation of vascular smooth muscle cells. J Physiol, 593: 3013–3030. https://doi.org/10.1113/jp270033 

Pan H, Xue C, Auerbach BJ, et al., 2020, Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation, 142: 2060–2075. https://doi.org/10.1161/circulationaha.120.048378

Chen PY, Qin L, Li G, et al., 2020, Smooth muscle cell reprogramming in aortic aneurysms. Cell Stem Cell, 26: 542–557.e511. https://doi.org/10.1016/j.stem.2020.02.013 

Lu S, Jolly AJ, Strand KA, et al., 2020, Smooth muscle-derived progenitor cell myofibroblast differentiation through KLF4 downregulation promotes arterial remodeling and fibrosis. JCI Insight, 5: e139445. https://doi.org/10.1172/jci.insight.139445 

Cao J, Yang Z, Xiao R, et al., 2020, Regenerative potential of pluripotent nontumorgenetic stem cells: Multilineage differentiating stress enduring cells (Muse cells). Regen Ther, 15: 92–96. https://doi.org/10.1016/j.reth.2020.04.011

Peng GY, Lin Y, Li JJ, et al., 2019, The application of induced pluripotent stem cells in pathogenesis study and gene therapy for vascular disorders: Current progress and future challenges. Stem Cells Int, 2019: 9613258. https://doi.org/10.1155/2019/9613258

Granata A, Serrano F, Bernard WG, et al., 2017, An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death. Nat Genet, 49: 97–109. https://doi.org/10.1038/ng.3723

Wang Y, Yin P, Bian GL, et al., 2017, The combination of stem cells and tissue engineering: An advanced strategy for blood vessels regeneration and vascular disease treatment. Stem Cell Res Ther, 8: 194. https://doi.org/10.1186/s13287-017-0642-y 

Rurali E, Perrucci GL, Pilato CA, et al., 2018, Precise therapy for thoracic aortic aneurysm in Marfan syndrome: A puzzle nearing its solution. Prog Cardiovasc Dis, 61: 328–335. https://doi.org/10.1016/j.pcad.2018.07.020

Hu K, Li J, Zhu K, et al., 2017, Generation of an induced pluripotent stem cell line from a Loeys-Dietz syndrome patient with transforming growth factor-beta receptor-2 gene mutation. Stem Cell Res, 20: 115–117. https://doi.org/10.1016/j.scr.2017.03.012

Williams IM, Wu JC, 2019, Generation of endothelial cells from human pluripotent stem cells. Arterioscler Thromb Vasc Biol, 39: 1317–1329. https://doi.org/10.1161/atvbaha.119.312265

Iida Y, Sawa S, Shimizu H, 2018, Optimal time for pharmacological treatment of abdominal aortic aneurysm. Curr Drug Targets, 19: 1297–1301. https://doi.org/10.2174/1389450119666171227225008

Hashizume R, Yamawaki-Ogata A, Ueda Y, et al., 2011, Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice. J Vasc Surg, 54: 1743–1752. https://doi.org/10.1016/j.jvs.2011.06.109

Li X, Wen H, Lv J, et al., 2022, Therapeutic efficacy of mesenchymal stem cells for abdominal aortic aneurysm: A meta-analysis of preclinical studies. Stem Cell Res Ther, 13: 81. https://doi.org/10.1186/s13287-022-02755-w

Li K, Vela D, Migliati E, et al., 2021, Pilot study of endovascular delivery of mesenchymal stromal cells in the aortic wall in a pig model. Cell Transplant, 30: 9636897211010652. https://doi.org/10.1177/09636897211010652

Wen H, Wang M, Gong S, et al., 2020, Human umbilical cord mesenchymal stem cells attenuate abdominal aortic aneurysm progression in Sprague-Dawley rats: Implication of vascular smooth muscle cell phenotypic modulation. Stem Cells Dev, 29: 981–993. https://doi.org/10.1089/scd.2020.0058 

Dahal S, Swaminathan G, Carney S, et al., 2020, Pro-elastogenic effects of mesenchymal stem cell derived smooth muscle cells in a 3D collagenous milieu. Acta Biomater, 105: 180–190. https://doi.org/10.1016/j.actbio.2020.01.030

Sivaraman S, Hedrick J, Ismail S, et al., 2021, Generation and characterization of human mesenchymal stem cell-derived smooth muscle cells. Int J Mol Sci, 22: 10335. https://doi.org/10.3390/ijms221910335

Kozakai M, Narita Y, Yamawaki-Ogata A, et al., 2022, Alternative therapeutic strategy for existing aortic aneurysms using mesenchymal stem cell-derived exosomes. Expert Opin Biol Ther, 22: 95–104. https://doi.org/10.1080/14712598.2022.2005575 

Hosoyama K, Wakao S, Kushida Y, et al., 2018, Intravenously injected human multilineage-differentiating stress-enduring cells selectively engraft into mouse aortic aneurysms and attenuate dilatation by differentiating into multiple cell types. J Thorac Cardiovasc Surg, 155: 2301–2313.e4. https://doi.org/10.1016/j.jtcvs.2018.01.098

Hosoyama K, Saiki Y, 2018, Muse cells and aortic aneurysm. Adv Exp Med Biol, 1103: 273–291. https://doi.org/10.1007/978-4-431-56847-6_15

Parvizi M, Harmsen MC, 2015, Therapeutic prospect of adipose-derived stromal cells for the treatment of abdominal aortic aneurysm. Stem Cells Dev, 24: 1493–1505. https://doi.org/10.1089/scd.2014.0517

Blose KJ, Ennis TL, Arif B, et al., 2014, Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression. Regen Med, 9: 733– 741. https://doi.org/10.2217/rme.14.61

Zilberman B, Kooragayala K, Lou J, et al., 2022, Treatment of abdominal aortic aneurysm utilizing adipose-derived mesenchymal stem cells in a porcine model. J Surg Res, 278: 247–256. https://doi.org/10.1016/j.jss.2022.04.064

Mulorz J, Shayan M, Hu C, et al., 2021, peri-Adventitial delivery of smooth muscle cells in porous collagen scaffolds for treatment of experimental abdominal aortic aneurysm. Biomater Sci, 9: 6903–6914. https://doi.org/10.1039/d1bm00685a

Shen M, Liu C, Wu JC, 2022, Generation of embryonic origin-specific vascular smooth muscle cells from human induced pluripotent stem cells. Methods Mol Biol, 2429: 233–246. https://doi.org/10.1007/978-1-0716-1979-7_15

Doss MX, Sachinidis A, 2019, Current challenges of iPSC-based disease modeling and therapeutic implications. Cells, 8: 403. https://doi.org/10.3390/cells8050403 

Davis JP, Salmon M, Pope NH, et al., 2015, Attenuation of aortic aneurysms with stem cells from different genders. J Surg Res, 199: 249–258. https://doi.org/10.1016/j.jss.2015.04.025

Sharma AK, Salmon MD, Lu G, et al., 2016, Mesenchymal stem cells attenuate NADPH oxidase-dependent high mobility group box 1 production and inhibit abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol, 36: 908–918. https://doi.org/10.1161/atvbaha.116.307373

Schneider F, Saucy F, de Blic R, et al., 2013, Bone marrow mesenchymal stem cells stabilize already-formed aortic aneurysms more efficiently than vascular smooth muscle cells in a rat model. Eur J Vasc Endovasc Surg, 45: 666–672. https://doi.org/10.1016/j.ejvs.2013.03.007

Parvizi M, Petersen AH, van Spreuwel-Goossens CA, et al., 2018, Perivascular scaffolds loaded with adipose tissue-derived stromal cells attenuate development and progression of abdominal aortic aneurysm in rats. J Biomed Mater Res A, 106, 2494–2506. https://doi.org/10.1002/jbm.a.36445

Tian X, Fan J, Yu M, et al., 2014, Adipose stem cells promote smooth muscle cells to secrete elastin in rat abdominal aortic aneurysm. PLoS One, 9: e108105. https://doi.org/10.1371/journal.pone.0108105

Yamawaki-Ogata A, Fu X, Hashizume R, et al., 2014, Therapeutic potential of bone marrow-derived mesenchymal stem cells in formed aortic aneurysms of a mouse model. Eur J Cardiothorac Surg, 45: e156–e165. https://doi.org/10.1093/ejcts/ezu018

Fu XM, Yamawaki-Ogata A, Oshima H, et al., 2013, Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse. J Transl Med, 11, 175. https://doi.org/10.1186/1479-5876-11-175

Yamawaki-Ogata A, Oshima H, Usui A, et al., 2017, Bone marrow-derived mesenchymal stromal cells regress aortic aneurysm via the NF-kB, Smad3 and Akt signaling pathways. Cytotherapy, 19: 1167–1175. https://doi.org/10.1016/j.jcyt.2017.07.010

Zidi M, Allaire E, 2015, Mechanical behavior of abdominal aorta aneurysm in rat model treated by cell therapy using mesenchymal stem cells. Biomech Model Mechanobiol, 14: 185–194. https://doi.org/10.1007/s10237-014-0586-4 

Wang SK, Green LA, Gutwein AR, et al., 2018, Rationale and design of the ARREST trial investigating mesenchymal stem cells in the treatment of small abdominal aortic aneurysm. Ann Vasc Surg, 47: 230–237. https://doi.org/10.1016/j.avsg.2017.08.044